About The Cover
Bone marrow plasma cells from a multiple myeloma patient after CD138 bead purification. See Tschumper et al.
Table of Contents
Editorial Comments
Pro-malignant properties of STAT3 during chronic inflammation
| Pro-malignant properties of STAT3 during chronic inflammation |
|
https://doi.org/10.18632/oncotarget.482 Marco Demaria, and Valeria Poli |
| 359-360 |
| PDF | HTML | How to cite |
Attacking tumor cells with a dual ligand for innate immune receptors
| Attacking tumor cells with a dual ligand for innate immune receptors |
|
https://doi.org/10.18632/oncotarget.484 Johan Garaude, and J. Magarian Blander |
| 361-362 |
| Abstract | PDF | HTML | How to cite |
Accelerating cancer evolution: a dark side of SIRT1 in genome maintenance
| Accelerating cancer evolution: a dark side of SIRT1 in genome maintenance |
|
https://doi.org/10.18632/oncotarget.487 WenYong Chen |
| 363-364 |
| Abstract | PDF | HTML | How to cite |
Reviews
Targeting Cancer Gene Therapy with Magnetic Nanoparticles
| Targeting Cancer Gene Therapy with Magnetic Nanoparticles |
|
https://doi.org/10.18632/oncotarget.490 Charles Li, Linda Li, and Andrew C. Keate |
| 365-370 |
| Abstract | PDF | HTML | How to cite |
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
| Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment |
|
https://doi.org/10.18632/oncotarget.477 Alberto M. Martelli, Francesca Chiarini, Camilla Evangelisti, Alessandra Cappellini, Francesca Buontempo, Daniela Bressanin, Milena Fini, and James A. McCubrey |
| 371-394 |
| Abstract | PDF | HTML | How to cite |
Brief Reports
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
| Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
|
https://doi.org/10.18632/oncotarget.488 Sílvia Cufí, Bruna Corominas-Faja, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Joan Dorca, Joaquim Bosch-Barrera, Begoña Martin-Castillo, and Javier A Menendez |
| 395-398 |
| Abstract | PDF | HTML | How to cite |
Research Papers
Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation
| Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation |
|
https://doi.org/10.18632/oncotarget.473 Veronique Mathieu, Christine Pirker, Wolfgang M Schmidt, Sabine Spiegl-Kreinecker, Daniela Lötsch, Petra Heffeter, Balazs Hegedus, Michael Grusch, Robert Kiss, and Walter Berger |
| 399-413 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
| Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance |
|
https://doi.org/10.18632/oncotarget.519 Daniel J. O'Shannessy, Gordon Yu, Robert Smale, Yao-Shi Fu, Sunil Singhal, Robert P. Thiel, Elizabeth B. Somers, and Anil Vachani |
| 414-425 |
| Abstract | PDF | HTML | How to cite |
Properties of Mechano-Transduction via Simulated Microgravity and its Effects on Intracellular Trafficking of VEGFR’s
| Properties of Mechano-Transduction via Simulated Microgravity and its Effects on Intracellular Trafficking of VEGFR’s |
|
https://doi.org/10.18632/oncotarget.472 Andrew Puca, Giuseppe Russo, and Antonio Giordano |
| 426-434 |
| Abstract | PDF | HTML | How to cite |
Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK
| Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK |
|
https://doi.org/10.18632/oncotarget.483 Prabodh K. Kandala, and Sanjay K. Srivastava |
| 435-449 |
| Abstract | PDF | HTML | How to cite |
Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes.
| Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes. |
|
https://doi.org/10.18632/oncotarget.480 Lasse S. Kristensen, Michael P. Raynor, Ida L. Candiloro, and Alexander Dobrovic |
| 450-461 |
| Abstract | PDF | HTML | How to cite |
On the presence and role of human gene-body DNA methylation
| On the presence and role of human gene-body DNA methylation |
|
https://doi.org/10.18632/oncotarget.497 Daudi Jjingo, Andrew B. Conley, Soojin V. Yi, Victoria V. Lunyak, and I. King Jordan |
| 462-474 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Singular v Dual Inhibition of SNF2L and Its Isoform, SNF2LT, Have Similar Effects on DNA Damage but Opposite Effects on the DNA Damage Response, Cancer Cell Growth Arrest and Apoptosis
| Singular v Dual Inhibition of SNF2L and Its Isoform, SNF2LT, Have Similar Effects on DNA Damage but Opposite Effects on the DNA Damage Response, Cancer Cell Growth Arrest and Apoptosis |
|
https://doi.org/10.18632/oncotarget.479 Yin Ye, Yi Xiao, Wenting Wang, Jian-Xin Gao, Kurtis Yearsley, Quintao Yan, and Sanford H. Barsky |
| 475-489 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients
| BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients |
|
https://doi.org/10.18632/oncotarget.481 Thomas Cluzeau, Guillaume Robert, Nicolas Mounier, Jean Michel Karsenti, Maeva Dufies, Alexandre Puissant, Arnaud Jacquel, Aline Renneville, Claude Preudhomme, Jill Patrice Cassuto, Sophie Raynaud, Frederic Luciano, and Patrick Auberger |
| 490-501 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Methodological Reports
Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing
| Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing |
|
https://doi.org/10.18632/oncotarget.469 Renee C. Tschumper, Yan W. Asmann, Asif Hossain, Paul M. Huddleston, Xiaosheng Wu, Angela Dispenzieri, Bruce W. Eckloff, and Diane F. Jelinek |
| 502-513 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals